Genomics in Multiple Myeloma : Multiple MyelomaMUNSHI, Nikhil C; AVET-LOISEAU, Herve.Clinical cancer research (Print). 2011, Vol 17, Num 6, pp 1234-1242, issn 1078-0432, 9 p.Article

New Strategies in the Treatment of Multiple MyelomaMUNSHI, Nikhil C; ANDERSON, Kenneth C.Clinical cancer research (Print). 2013, Vol 19, Num 13, pp 3337-3344, issn 1078-0432, 8 p.Article

Recent advances in the management of multiple myelomaMUNSHI, Nikhil C.Seminars in hematology. 2004, Vol 41, Num 2, pp 21-26, issn 0037-1963, 6 p., SUP4Article

Immune TherapiesPRABHALA, Rao H; MUNSHI, Nikhil C.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, x-xi, 1217-1230 [16 p.]Article

Multicentric plasma cell variant of Castleman's disease with cutaneous involvementKLEIN, Walter M; RENCIC, Adrienne; MUNSHI, Nikhil C et al.Journal of cutaneous pathology. 2004, Vol 31, Num 6, pp 448-452, issn 0303-6987, 5 p.Article

Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disordersBAE, Jooeun; TAI, Yu-Tzu; ANDERSON, Kenneth C et al.British journal of haematology. 2011, Vol 155, Num 3, pp 349-361, issn 0007-1048, 13 p.Article

A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaBAE, Jooeun; WEIHUA SONG; SMITH, Robert et al.British journal of haematology. 2012, Vol 157, Num 6, pp 687-701, issn 0007-1048, 15 p.Article

Dysfunctional homologous recombination mediates genomic instability and progression in myelomaSHAMMAS, Masood A; SHMOOKLER REIS, Robert J; KOLEY, Hemanta et al.Blood. 2009, Vol 113, Num 10, pp 2290-2297, issn 0006-4971, 8 p.Article

Telomerase inhibition and cell growth arrest after Telomestatin treatment in multiple myelomaSHAMMAS, Masood A; REIS, Robert J; CHENG LI et al.Clinical cancer research. 2004, Vol 10, Num 2, pp 770-776, issn 1078-0432, 7 p.Article

The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma : Interplay of growth factors, their receptors and stromal interactionsMITSIADES, Constantine S; MITSIADES, Nicholas S; MUNSHI, Nikhil C et al.European journal of cancer (1990). 2006, Vol 42, Num 11, pp 1564-1573, issn 0959-8049, 10 p.Article

Podocyte injury associated glomerulopathies induced by pamidronateBARRI, Yousri M; MUNSHI, Nikhil C; SUKUMALCHANTRA, Suteetat et al.Kidney international. 2004, Vol 65, Num 2, pp 634-641, issn 0085-2538, 8 p.Article

Antisense p53 transduction leads to overexpression of bcl-2 and dexamethasone resistance in multiple myelomaIYER, Rajaraman; LIEMING DING; BATCHU, Ramesh B et al.Leukemia research. 2003, Vol 27, Num 1, pp 73-78, issn 0145-2126, 6 p.Article

Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate TherapyPATEL, Chirayu G; YEE, Andrew J; ANDERSON, Kenneth C et al.Clinical cancer research (Print). 2014, Vol 20, Num 15, pp 3955-3961, issn 1078-0432, 7 p.Article

Significant Biological Role of Sp1 Transactivation in Multiple MyelomaFULCINITI, Mariateresa; AMIN, Samir; HIDESHIMA, Teru et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6500-6509, issn 1078-0432, 10 p.Article

A proto-oncogene BCL6 is up-regulated in the bone marrow microenvironment in multiple myeloma cellsHIDESHIMA, Teru; MITSIADES, Constantine; ANDERSON, Kenneth C et al.Blood. 2010, Vol 115, Num 18, pp 3772-3775, issn 0006-4971, 4 p.Article

Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cellsHIDESHIMA, Teru; IKEDA, Hiroshi; ANDERSON, Kenneth C et al.Blood. 2009, Vol 114, Num 5, pp 1046-1052, issn 0006-4971, 7 p.Article

CS1 promotes multiple myeloma cell adhesion, clonogenic growth, and tumongenicity via c-maf-mediated interactions with bone marrow stromal cellsTAI, Yu-Tzu; SOYDAN, Ender; PODAR, Klaus et al.Blood. 2009, Vol 113, Num 18, pp 4309-4318, issn 0006-4971, 10 p.Article

Clinical, Radiographic, and Biochemical Characterization of Multiple Myeloma Patients with Osteonecrosis of the JawRAJE, Noopur; WOO, Sook-Bin; CONNELL, Brendan et al.Clinical cancer research. 2008, Vol 14, Num 8, pp 2387-2395, issn 1078-0432, 9 p.Article

Inhibition of Akt induces significant downregulation of survivin and cytotoxicity in human multiple myeloma cellsHIDESHIMA, Teru; CATLEY, Laurence; IKEDA, Hiroshi et al.British journal of haematology. 2007, Vol 138, Num 6, pp 783-791, issn 0007-1048, 9 p.Article

Targeting MEK induces myeloma-cell cytotoxicity and inhibits osteoclastogenesis. CommentaryQUESNEL, Bruno; TAI, Yu-Tzu; PODAR, Klaus et al.Blood. 2007, Vol 110, Num 5, issn 0006-4971, 1402-1403, 1656-1663 [10 p.]Article

The Role of the Bone Marrow Microenvironment in the Pathophysiology of Myeloma and Its Significance in the Development of More Effective TherapiesMITSIADES, Constantine S; MCMILLIN, Douglas W; KLIPPEL, Steffen et al.Hematology/oncology clinics of North America. 2007, Vol 21, Num 6, issn 0889-8588, vii-viii, 1007-1034 [30 p.]Article

Dysfunctional T regulatory cells in multiple myelomaPRABHALA, Rao H; NERI, Paola; ANDERSON, Kenneth C et al.Blood. 2006, Vol 107, Num 1, pp 301-304, issn 0006-4971, 4 p.Article

Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea : biologic activity and therapeutic implicationsSHAMMAS, Masood A; NERI, Paola; GOYAL, Raj K et al.Blood. 2006, Vol 108, Num 8, pp 2804-2810, issn 0006-4971, 7 p.Article

A SCID-hu in vivo model of human Waldenström macroglobulinemia. CommentaryTASSONE, Pierfrancesco; NERI, Paola; MUNSHI, Nikhil C et al.Blood. 2005, Vol 106, Num 4, pp 1143-1144, issn 0006-4971, 6 p.Article

Immunomodulatory drug lenalidomide (CC-5013, IMiD3) augments anti-CD40 SGN-40-lnduced cytotoxicity in human multiple myeloma : Clinical implicationsTAI, Yu-Tzu; LI, Xian-Feng; SCHLOSSMAN, Robert et al.Cancer research (Baltimore). 2005, Vol 65, Num 24, pp 11712-11720, issn 0008-5472, 9 p.Article